-$27.14 (-6.95%)
| Source | Headline |
|---|---|
|
HCA Healthcare Trims 2026 Profit Outlook, Stock Falls
HCA Healthcare Inc.'s (NYSE:HCA) stock is trading lower on Tuesday after cutting its fiscal 2026 earnings guidance from $29.10-$31.50 to $28.70-$30.50. benzinga.com - 2026-07-14 09:41:48 |
|
HCA Healthcare Stock Falls as Uninsured Patients and Declining Surgeries Dent Outlook
HCA Healthcare stock falls after the hospital chain operator lowers its full-year profit outlook as uninsured patients rise in the second quarter. barrons.com - 2026-07-14 09:16:00 |
|
HCA Healthcare Shares Drop After Quarterly Earnings Squeezed by Payer Mix Shifts
The for-profit operator of healthcare facilities scaled back financial guidance for the year following payer mix shifts due to health insurance exchanges. wsj.com - 2026-07-14 09:08:00 |
|
HCA Healthcare, Inc. 2nd Quarter 2026 Earnings Conference Call
HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast: What: HCA Healthcare, Inc. 2Q 2026 Earnings Call When: Friday, July 24, 2026, at 9:00 AM Ce gurufocus.com - 2026-07-14 08:00:00 |
|
HCA Healthcare Previews Second Quarter 2026 Results
[url="]HCA Healthcare, Inc.[/url] (NYSE: HCA) today announced preliminary financial and operating results for the second quarter ended June 30, 2026. The preli gurufocus.com - 2026-07-14 08:00:00 |
|
HCA reports preliminary quarterly revenue above expectations
HCA Healthcare on Tuesday reported preliminary second-quarter revenue above Wall Street expectations. reuters.com - 2026-07-14 07:49:41 |
|
HCA Healthcare, Inc. 2nd Quarter 2026 Earnings Conference Call
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast: What: HCA Healthcare, Inc. 2Q 2026 Earnings Call When: Friday, July 24, 2026, at 9:00 AM Central (10:00 AM Eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, [email protected] If you are unable to listen during the live webcast, the call will be. businesswire.com - 2026-07-14 07:35:00 |
|
HCA Healthcare Previews Second Quarter 2026 Results
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced preliminary financial and operating results for the second quarter ended June 30, 2026. The preliminary financial and operating results are subject to finalization of the Company's quarterly financial and accounting procedures. HCA anticipates revenues in the second quarter of 2026 to approximate $20.230 billion, compared to $18.605 billion in the second quarter of 2025. Net income attributable to HCA Healthcare. businesswire.com - 2026-07-14 07:30:00 |
|
Is the Options Market Predicting a Spike in HCA Healthcare Stock?
Investors need to pay close attention to HCA stock based on the movements in the options market lately. zacks.com - 2026-07-08 13:21:03 |
|
This HCA Healthcare Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. benzinga.com - 2026-07-08 08:24:10 |
|
Top 50 High-Quality Dividend Growth Stocks For July 2026
I track a curated universe of 50 high-quality dividend growth stocks to identify opportune entry points based on valuation and future return potential. Year-to-date through June, the investable universe returned 8.69%, trailing SPY (10.10%) and SCHD (17.50%), but several individual stocks outperformed significantly. Currently, 39 out of 50 stocks offer a forward return estimate of at least 10%, with 22 appearing potentially undervalued by my free cash flow model. seekingalpha.com - 2026-07-08 07:42:40 |
|
HCA Healthcare's Fall Shouldn't Be Construed As Failing Health
HCA Healthcare remains a soft 'buy' despite recent underperformance, with fundamentals improving and shares attractively priced on an absolute basis. HCA's revenue and profitability continue to grow, driven by Medicare/Medicaid, increased equivalent admissions, and higher revenue per admission, even as the physical footprint shrinks. Management sustains shareholder returns through dividends and aggressive buybacks, with a 6.9% reduction in share count and $9.18 billion in remaining buyback capacity. seekingalpha.com - 2026-07-07 22:20:41 |
|
Your Hospital’s HR Won’t Tell You This: Nurses Can Legally Shield $49,000 a Year by Stacking a 403(b) and a 457(b)
Your hospital's benefits packet lists a 403(b), and it may also quietly list a 457(b) on a separate page. Human resources rarely explains what happens when a nurse funds both: the IRS treats them as separate buckets, not one aggregate limit. That is the loophole. For nurses employed by nonprofit hospitals, public health systems, or... Your Hospital's HR Won't Tell You This: Nurses Can Legally Shield $49,000 a Year by Stacking a 403(b) and a 457(b) 247wallst.com - 2026-07-07 17:13:53 |
|
Can HCA's Capacity Expansion Strategy Fuel Its Long-Term Growth?
HCA is expanding hospitals, ERs and outpatient sites while investing billions in new capacity to support future healthcare demand and long-term growth. zacks.com - 2026-07-07 13:25:56 |
|
Earnings Growth & Price Strength Make HCA Healthcare (HCA) a Stock to Watch
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List. zacks.com - 2026-07-06 10:30:35 |
|
Can HCA's Gene Therapy Milestone Drive Long-Term Growth?
HCA Healthcare highlights promising pediatric CRISPR gene therapy results as expanding specialty care and research investments support its long-term growth strategy. zacks.com - 2026-07-01 14:06:05 |
|
HCA Healthcare Announces New England Journal of Medicine Study Highlighting Advances in CRISPR-based Therapy for Children
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced new research published in The New England Journal of Medicine (NEJM) demonstrating promising results from a gene-editing therapy being investigated in children ages 5-11 with severe sickle cell disease and transfusion-dependent beta thalassemia. Sickle cell disease and beta thalassemia are inherited blood disorders that can cause serious, lifelong complications b. businesswire.com - 2026-06-29 08:30:00 |
|
HCA Healthcare (HCA) is a Top-Ranked Growth Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. zacks.com - 2026-06-26 10:46:07 |
|
Why HCA Healthcare (HCA) is a Top Stock for the Long-Term
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service. zacks.com - 2026-06-25 10:31:12 |
|
Why HCA Healthcare (HCA) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. zacks.com - 2026-06-24 10:41:33 |
|
Healthcare Added 35,200 Jobs—3 Stocks Positioned to Benefit
The May Jobs report told a familiar story for investors in healthcare stocks. The sector added 35,200 positions last month, led by ambulatory health services at 25,700 and hospitals at 6,000. marketbeat.com - 2026-06-15 09:50:25 |
|
Is HCA Undervalued? DCF Says Worth $765
On June 10, 2026, we present a detailed DCF analysis for HCA Healthcare Inc (HCA), a company currently facing a challenging price performance context with a yea gurufocus.com - 2026-06-10 07:03:00 |
|
Mission Bio and Human Cell Atlas Collaborate to Expand Access to Single-Cell Multiomics Ahead of HCA 2026 Meeting
SAN FRANCISCO--(BUSINESS WIRE)--Mission Bio, the leader in single-cell multiomics solutions, today announced a collaboration with the Human Cell Atlas (HCA), a global consortium working to create comprehensive reference maps of all human cells to advance the understanding, diagnosis, and treatment of disease. The announcement comes ahead of the upcoming Human Cell Atlas General Meeting 2026, taking place June 16–18 in Boston, where Mission Bio will participate alongside leading researchers and. businesswire.com - 2026-06-09 09:00:00 |
|
Vizgen® to Advance Cell Atlases with New Volumetric Tissue Mapping Spatial Data and Services at HCA 2026 Meeting
WALTHAM, Mass.--(BUSINESS WIRE)-- #HCA--Vizgen, Inc., a leader in spatial multiomics and developer of the MERSCOPE Ultra™ Platform, today announced it will debut a 3D Volumetric Tissue Mapping dataset in neurodegenerative brain tissue using MERFISH 2.0™ chemistry on the MERSCOPE Ultra Platform at the Human Cell Atlas (HCA) General Meeting, June 16-18, in Boston. The company will also launch Volumetric Tissue Mapping services and a new Cell Atlasing Hub, a central resource for the cell atlasing communi. businesswire.com - 2026-06-08 08:00:00 |
|
Top 50 High-Quality Dividend Growth Stocks For June 2026
I track a curated universe of 50 high-quality dividend growth stocks to identify attractive entry points based on valuation and forward return potential. Year-to-date, the universe lags SPY and SCHD, but select names like LRCX (+343%) and KLAC (+208%) have dramatically outperformed since inception. Currently, 40 stocks offer forward return estimates of at least 10%, with 24 appearing potentially undervalued by my free cash flow model. seekingalpha.com - 2026-06-08 04:51:11 |
|
3 Beaten-Down Stocks to Buy and Hold Forever
Don't wait too long to buy the dip on these stocks. fool.com - 2026-06-02 04:15:00 |
|
HCA Healthcare to Acquire CHCP to Strengthen Workforce Development
HCA plans to acquire CHCP, expanding healthcare education efforts and boosting its pipeline of trained professionals across hospitals and care sites. zacks.com - 2026-05-28 11:01:20 |
|
HCA Healthcare Announces Agreement to Acquire The College of Health Care Professions
NASHVILLE, Tenn. & HOUSTON--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, and The College of Health Care Professions (CHCP), one of the largest allied healthcare training providers in Texas, today announced an agreement for HCA Healthcare to acquire ownership of CHCP. CHCP provides healthcare education to more than 8,000 students annually across 10 campuses throughout Texas and online. “The College of Health Care Professions has built a stro. businesswire.com - 2026-05-27 16:30:00 |
|
Is HCA Undervalued? DCF Says Worth $765
On May 27, 2026, we delve into the DCF analysis for HCA Healthcare Inc (HCA), a company currently facing a challenging price performance with a year-to-date dec gurufocus.com - 2026-05-27 07:36:00 |
|
HCA Healthcare, Inc. (HCA) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
HCA Healthcare, Inc. (HCA) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript seekingalpha.com - 2026-05-20 14:11:01 |
|
HCA Healthcare Colleagues Volunteer More Than 41,800 Hours During Annual Days of Service Initiative
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced the results of its seventh annual We Show Up for Our Communities days of service volunteer initiative. In alignment with National Volunteer Month, HCA Healthcare colleagues across the country donated their time and expertise to help improve the health and well-being of the communities the company serves. “Caring for our communities is at the heart of HCA Healthca. businesswire.com - 2026-05-19 08:30:00 |
|
HCA DCF Analysis: Intrinsic Value $765 vs Price $423
On May 19, 2026, we delve into the DCF analysis for HCA Healthcare Inc (HCA), a company that has experienced a price performance of -0.8% over the past week, -1 gurufocus.com - 2026-05-19 07:36:00 |
|
HCA DCF Analysis: Intrinsic Value $765 vs Price $429
On May 08, 2026, we delve into the DCF analysis for HCA Healthcare Inc (HCA), a company that has seen varied price performance recently. Over the past week, the gurufocus.com - 2026-05-08 07:53:00 |
|
HCA Healthcare, Inc. to Present at May Conference
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) is scheduled to present at the following healthcare conference: May 20, 2026, at 11:30am ET at the RBC Global Healthcare Conference A link to the live audio webcast, where applicable, and copies of any related presentation materials will be made available at the Investor Relations section of the Company's website, www.hcahealthcare.com. Dates and times may be subject to change, please check the conference schedule or the Invest. businesswire.com - 2026-04-30 16:30:00 |
|
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now. zacks.com - 2026-04-30 09:56:13 |
|
Comerica Bank Sells 3,248 Shares of HCA Healthcare, Inc. $HCA
Comerica Bank reduced its position in shares of HCA Healthcare, Inc. (NYSE: HCA) by 9.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 30,860 shares of the company's stock after selling 3,248 shares during the period. Comerica Bank's holdings in defenseworld.net - 2026-04-29 14:23:15 |
|
HCA Healthcare Inc (HCA) Shares Surge 3.1% -- What GF Score of 97 Tells Investors
On April 27, 2026, HCA Healthcare Inc (HCA) shares rose 3.1% today, bringing the current price to $445.77. Over the past year, the stock has experienced a notab gurufocus.com - 2026-04-27 17:04:00 |
|
HCA Healthcare Names Cynthia Cifuentes-Finkel Senior Vice President of Marketing and Corporate Affairs
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare (NYSE: HCA) today announced that Cynthia Cifuentes-Finkel has been named senior vice president of marketing and corporate affairs, effective June 8, 2026. She will report to Mike McAlevey, executive vice president, chief legal and administrative officer, and will lead enterprise marketing, corporate communications, and stakeholder engagement in support of HCA Healthcare's enterprise growth priorities. “Cynthia is a strategic and accomplished lea. businesswire.com - 2026-04-27 17:00:00 |
|
These Analysts Slash Their Forecasts On HCA Healthcare After Q1 Results
HCA Healthcare Inc. (NYSE:HCA) posted in-line earnings for the first quarter on Friday. benzinga.com - 2026-04-27 10:40:04 |
|
HCA Announces Proposed Public Offering of Senior Notes
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced that its wholly owned subsidiary, HCA Inc., proposes to offer senior notes, subject to market and other considerations. Actual terms of the senior notes, including maturity, interest rate and principal amount, will depend on market conditions at the time of pricing. HCA Inc. intends to use the net proceeds from this offering for general corporate purposes, which may include the repayment of outstanding borrowing. businesswire.com - 2026-04-27 08:24:00 |
|
HCA Healthcare, Inc. $HCA Shares Sold by Calamos Advisors LLC
Calamos Advisors LLC decreased its holdings in HCA Healthcare, Inc. (NYSE: HCA) by 3.9% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 48,373 shares of the company's stock after selling 1,964 shares during the quarter. Calamos Advisors LLC's holdings in HCA Healthcare defenseworld.net - 2026-04-25 03:58:55 |
|
HCA Healthcare, Inc. (NYSE:HCA) Given Consensus Rating of “Moderate Buy” by Analysts
HCA Healthcare, Inc. (NYSE: HCA - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the twenty-four ratings firms that are presently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, seven have given a hold rating and sixteen have assigned a buy rating to defenseworld.net - 2026-04-25 02:30:51 |
|
HCA Healthcare Inc (HCA) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amid Operational Challenges
Revenue Increase: 4.3% compared to the first quarter last year.Adjusted EBITDA Increase: Almost 2% year-over-year.Diluted Earnings Per Share (Adjusted): Increa gurufocus.com - 2026-04-25 02:04:00 |
|
HCA Healthcare: Policy Pressures May Be Limiting Admissions (Upgrade)
HCA Healthcare is upgraded to "Hold" after a 12% pullback, and is now trading near fair value with a 7% free cash flow yield. Q1 results were mixed: EPS matched expectations, revenue grew 4%, but surgical volumes softened and margins retraced 50 bps. Policy headwinds, including Medicaid and ACA subsidy rollbacks, are expected to temper growth to 2%-3% annually over the next several years. seekingalpha.com - 2026-04-24 14:42:41 |
|
HCA Healthcare, Inc. (HCA) Q1 2026 Earnings Call Transcript
HCA Healthcare, Inc. (HCA) Q1 2026 Earnings Call Transcript seekingalpha.com - 2026-04-24 14:31:36 |
|
HCA Healthcare Q1 Earnings Miss Estimates on Rising Expenses
HCA's Q1 EPS misses estimates as rising expenses and weaker surgeries weigh despite modest revenue growth and gains in ER visits. zacks.com - 2026-04-24 12:50:57 |
|
HCA Healthcare (HCA) Faces Decline After Q1 Results and FY26 Guidance
HCA Healthcare (HCA) is experiencing a significant drop in trading following its Q1 earnings report and reaffirmation of FY26 guidance. The mixed results stem p gurufocus.com - 2026-04-24 12:14:00 |
|
HCA (HCA) Reports Q1 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for HCA (HCA) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. zacks.com - 2026-04-24 10:33:02 |
|
HCA Healthcare (HCA) Q1 Earnings and Revenues Miss Estimates
HCA Healthcare (HCA) came out with quarterly earnings of $7.15 per share, missing the Zacks Consensus Estimate of $7.17 per share. This compares to earnings of $6.45 per share a year ago. zacks.com - 2026-04-24 09:10:24 |
|
Is HCA Healthcare (HCA) Overvalued After Q1 2026 EPS Miss and Revenue Beat? EPS $7.15 vs $7.18 est; Revenue $19.109B vs $19.103B est -- GF Score 95/100, GF Valuation: 9.9% Overvalued
On April 24, 2026, HCA Healthcare Inc (HCA) released its 8-K filing reporting financial and operating results for the first quarter ended March 31, 2026. The co gurufocus.com - 2026-04-24 07:31:00 |